ストックスクリーナーアプリを入手
5.26
0.19%
-0.010
プレマーケット:
5.33
0.07
+1.33%
前日終値:
$5.27
開ける：
$5.27
24時間の取引高:
415.85K
Relative Volume:
0.61
時価総額：
$359.90M
収益：
-
当期純損益:
$-96.66M
株価収益率:
-2.4465
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+11.44%
1か月 パフォーマンス:
+8.90%
6か月 パフォーマンス:
+5.84%
1年 パフォーマンス:
-56.24%
1日の値動き範囲:
$5.15
$5.35
1週間の範囲:
$4.47
$5.58
52週間の値動き範囲:
$2.86
$13.93
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.26 | 361.70M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Is it too late to sell Olema Pharmaceuticals Inc.Rate Hike & Growth Oriented Trading Recommendations - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
Combining price and volume data for Olema Pharmaceuticals Inc.2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Applying big data sentiment scoring on Olema Pharmaceuticals Inc.Portfolio Return Report & Weekly Breakout Stock Alerts - Newser
Identifying reversal signals in Olema Pharmaceuticals Inc.Trade Entry Summary & Scalable Portfolio Growth Ideas - Newser
How hedge fund analytics apply to Olema Pharmaceuticals Inc. stockPortfolio Risk Report & Comprehensive Market Scan Insights - Newser
Is Olema Pharmaceuticals Inc. in Accumulation Phase NowQuarterly Portfolio Report & Daily Chart Pattern Signals - sundaytimes.kr
What high frequency data says about Olema Pharmaceuticals Inc.2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Applying Elliott Wave Theory to Olema Pharmaceuticals Inc.July 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
What institutional flow reveals about Olema Pharmaceuticals Inc.Analyst Upgrade & Community Verified Watchlist Alerts - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $21.00 - MarketBeat
What’s next for Olema Pharmaceuticals Inc. stock price2025 Market Outlook & Growth Focused Investment Plans - Newser
Published on: 2025-08-13 05:28:51 - Newser
Volatility clustering patterns for Olema Pharmaceuticals Inc.Weekly Gains Report & Growth Focused Entry Point Reports - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $21.00 at Citigroup - Defense World
Key metrics from Olema Pharmaceuticals Inc.’s quarterly data2025 Macro Impact & Reliable Volume Spike Trade Alerts - Newser
Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals - Insider Monkey
A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $21 to $28 - 富途牛牛
Olema Pharmaceuticals Stays On Track Despite Wider Losses - Finimize
What makes Olema Pharmaceuticals Inc. stock price move sharplyReal-Time Entry Signals for Top Stocks - Newser
Does Olema Pharmaceuticals Inc. qualify in momentum factor screeningIntraday Price Forecast Using Volume Models - Newser
Olema Pharmaceuticals Advances Breast Cancer Therapies - TipRanks
Is Olema Pharmaceuticals Inc. a defensive stockAI Curated Investment Watch - thegnnews.com
Olema Pharma Q2 net loss widens to $43.8 mln - MarketScreener
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results - GlobeNewswire
Can Olema Pharmaceuticals Inc. Outperform Peers After Recent PullbackHigh Probability Trade Forecast Summary - beatles.ru
Momentum divergence signals in Olema Pharmaceuticals Inc. chartCapital Growth Summary Over Five Years - Newser
What to expect from Olema Pharmaceuticals Inc. in the next 30 daysSmart Entry Watchlist with Daily Analysis - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holdersTrend Reversal Probability Forecast Update - Newser
11 Best Short-Term Stocks to Invest in - Insider Monkey
Trendlines Converge — Decision Point for Olema Pharmaceuticals Inc.Consistent Income Focused Trade List Analyzed - beatles.ru
How to use a screener to detect Olema Pharmaceuticals Inc. breakoutsDaily Stock Watch Summary with Key Insights - Newser
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFundamental Forecast for Undervalued Stocks - Newser
Can a trend reversal in Olema Pharmaceuticals Inc. lead to recoveryRisk Managed Watchlist with Breakout Picks - Newser
Olema Pharmaceuticals Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):